...
首页> 外文期刊>Archives of clinical infectious diseases. >Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran
【24h】

Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran

机译:多药抗性结核病的患病率:伊朗德黑兰六年的单中心回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Multidrug-resistant tuberculosis (MDR-TB) is one of the main challenges to TB control, particularly in developingcountries such as Iran. Continuous TB drug resistance surveillance is required for the effective management of TB patients.Methods: The antibiotic susceptibility patterns of clinical Mycobacterium tuberculosis isolates were retrospectively analyzed fromApril 2012 to March 2018. Conventional and molecular methods were used for the identification and drug susceptibility testing(DST) of M. tuberculosis isolates.Results: A total of 3,012 clinical specimens were collected form TB-suspected patients. Of them, 100 (3.3%) were culture-positive andassigned as M. tuberculosis by phenotypic and molecular methods. According to DST, 17 (17%) isolates were MDR-TB.Conclusions: Improved diagnosis and treatment of MDR-TB may lead to better control of the disease in Iran.
机译:背景:多药结核(MDR-TB)是TB控制的主要挑战之一,特别是在伊朗等发展中国家。 CTB患者的有效管理需要连续TB耐药性监测。方法:临床分枝杆菌分离株的抗生素敏感模式是从2012年至2012年3月的普遍分析。常规和分子方法用于鉴定和药物易感性测试(DST )肺结核分离物。结果:收集3,012个临床标本,形成TB可疑的患者。其中,100(3.3%)通过表型和分子方法作为培养阳性和划分的培养基。根据DST,17(17%)分离物是MDR-TB.Conclusions:改善MDR-TB的诊断和治疗可能导致伊朗的疾病更好地控制疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号